Biogen Shares Jump After FDA Delays Aducanumab Decision By 3 Months
vTv Therapeutics Shares Rise 50% After Setting A Date To Report Alzheimer's Trial Results
Pain Therapeutics Granted $3.5M For Alzheimer's Study, CEO Comments On Micro-Cap Volatility
Marijuana Could Help Treat Alzheimer's: Here's How It Would Work